Startseite The crystal structure of 10-(3,5-di(pyridin-4-yl)phenyl)-10H-phenoxazine dihydrate, C28H23N3O3
Artikel Open Access

The crystal structure of 10-(3,5-di(pyridin-4-yl)phenyl)-10H-phenoxazine dihydrate, C28H23N3O3

  • Zhuqing Yang ORCID logo und Meng Hou ORCID logo EMAIL logo
Veröffentlicht/Copyright: 17. Februar 2021

Abstract

C28H23N3O3, orthorhombic, Pna21 (no. 33), a = 29.0466(11) Å, b = 5.2448(3) Å, c = 14.4825(7) Å, V = 2206.32(19) Å3, Z = 4, Rgt(F) = 0.0511, wRref(F2) = 0.1341, T = 100.00(10) K.

CCDC no.: 2005449

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Yellow block
Size:0.11 × 0.10 × 0.09 mm
Wavelength:Cu Kα radiation (1.54184 Å)
μ:0.72 mm−1
Diffractometer, scan mode:SuperNova, ω
θmax, completeness:73.6°, >99%
N(hkl)measured, N(hkl)uniqueRint:5115, 3451, 0.044
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3078
N(param)refined:313
Programs:CrysAlisPRO [1],Olex2 [2], SHELX [3], [, 4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O10.58161 (9)0.8391 (6)0.5421 (2)0.0268 (7)
O20.26731 (12)−0.2047 (7)0.1738 (2)0.0383 (8)
H2A0.275046−0.1910310.2301700.057*
H2B0.272958−0.3593250.1603090.057*
O30.28471 (12)0.2850 (7)0.0964 (2)0.0344 (8)
H3A0.2912890.2703160.0394540.052*
H3B0.2794450.1333920.1142130.052*
N10.48623 (11)0.7683 (7)0.5591 (2)0.0227 (7)
N20.30080 (11)0.0061 (7)0.3443 (3)0.0259 (8)
N30.31019 (12)1.1718 (7)0.9043 (3)0.0269 (8)
C10.50318 (13)0.9385 (7)0.4933 (3)0.0195 (8)
C20.47539 (14)1.0774 (8)0.4340 (3)0.0235 (8)
H20.4437601.0498770.4343010.028*
C30.49392 (15)1.2570 (8)0.3740 (3)0.0268 (9)
H30.4747471.3477660.3343950.032*
C40.54122 (15)1.3010 (9)0.3731 (3)0.0299 (10)
H40.5536661.4256570.3348590.036*
C50.56957 (14)1.1569 (8)0.4299 (3)0.0264 (9)
H50.6012491.1820780.4283490.032*
C60.55133 (13)0.9784 (8)0.4880 (3)0.0224 (8)
C70.56438 (13)0.6440 (8)0.5951 (3)0.0239 (9)
C80.59565 (14)0.4858 (9)0.6381 (3)0.0279 (9)
H80.6270540.5122730.6300610.033*
C90.58026 (16)0.2865 (9)0.6937 (3)0.0318 (10)
H90.6013010.1823140.7240220.038*
C100.53346 (15)0.2442 (8)0.7035 (3)0.0287 (10)
H100.5229870.1097790.7397600.034*
C110.50210 (14)0.4030 (8)0.6591 (3)0.0255 (9)
H110.4707220.3735160.6660890.031*
C120.51680 (13)0.6035 (8)0.6047 (3)0.0203 (8)
C130.43737 (12)0.7376 (8)0.5723 (3)0.0208 (8)
C140.41241 (13)0.5878 (8)0.5121 (3)0.0213 (8)
H140.4266360.5192470.4601740.026*
C150.36546 (13)0.5383 (8)0.5288 (3)0.0229 (8)
C160.34472 (13)0.6503 (8)0.6048 (3)0.0212 (8)
H160.3137890.6177480.6164580.025*
C170.36885 (12)0.8097 (7)0.6640 (3)0.0202 (8)
C180.41629 (13)0.8506 (8)0.6477 (3)0.0218 (8)
H180.4332900.9529730.6875760.026*
C190.34707 (13)0.9408 (8)0.7437 (3)0.0203 (8)
C200.30840 (14)0.8407 (9)0.7885 (3)0.0254 (9)
H200.2940380.6944800.7663400.030*
C210.29182 (14)0.9641 (9)0.8670 (3)0.0295 (10)
H210.2658890.8957160.8953600.035*
C220.34666 (13)1.2712 (8)0.8591 (3)0.0259 (9)
H220.3600981.4185880.8825300.031*
C230.36508 (13)1.1655 (8)0.7799 (3)0.0244 (9)
H230.3896661.2450550.7504890.029*
C240.34144 (13)0.3636 (8)0.4644 (3)0.0207 (8)
C250.35050 (14)0.3649 (9)0.3708 (3)0.0255 (9)
H250.3705790.4851260.3461140.031*
C260.32970 (14)0.1873 (9)0.3136 (3)0.0283 (9)
H260.3360640.1938460.2507460.034*
C270.31010 (12)0.1817 (8)0.4969 (3)0.0220 (8)
H270.3017780.1778850.5589210.026*
C280.29166 (13)0.0071 (9)0.4352 (3)0.0255 (9)
H280.271778−0.1166070.4580980.031*

Source of material

In a representative experiment 3,5-di(pyridin-4-yl)aniline (2.0 mmol) reacted with CuBr2 (2.1 mmol) in a HBr (20 mL) solution at 50 °C to give 4,4’-(5-bromo-1,3-phenylene)dipyridine. This intermediate (1 mmol) was added to a methanolic solution (30 mL) containing 10H-phenoxazine (1.2 mmol). The reaction mixture was refluxed for 12 h at 120 °C under the catalysis of NaOBu-t and Pd(OAC)2. The precipitated residue was removed from the solution by filtration and then washed with methanol and chloroform. Crystals were obtained by slow evaporation of mixed solution of methanol and chloroform (3:1, v/v) at room temperature after a week.

Experimental details

The title compound was collected at 100 K on a Rigaku Oxford Diffraction Supernova Dual Source, Cu at Zero equipped with an AtlasS2 CCD using Cu Kα radiation. The data were collected and processed using CrysAlisPro [1]. The structures were solved by direct methods using Olex2 software [2], and the non-hydrogen atoms were located from the trial structure and then refined anisotropically with SHELXL-2018 [3] using a full-matrix least squares procedure based on F2. The weighted R factor, wR and goodness-of-fit S values were obtained based on F2. H atoms attached to C were included in calculated positions and refined as riding atoms, with d (N–H) = 0.86 Å, d(C–H) = 0.93 Å (aromatic). Their Uiso values were set to 1.2Ueq of the parent atoms. Water molecules were refined as rigid groups and HUiso was set to 1.5Ueq of the parent atom.

Comment

Phenoxazine derivatives have been identified in various biological systems including pigments and antibiotics [4], [5], [6] and extensively investigated in the past few decades because of their vast applications such as antimicrobial effects [7], [, 8], organic dyes [9], anti-cancer effects [10], [, 11] and pharmaceutical intermediates [12]. In particular, metal-free organic dyes with a core phenoxazine chromophore represent a rapidly growing field of research [13], [14], [15]. Here we report the crystal structure of a new phenoxazine derivative to expect a better understanding of this structure.

The asymmetric unit of the title structure contains one 10-(3,5-di(pyridin-4-yl)phenyl)-10H-phenoxazine and two water molecules. From the molecular structure, it can be calculated that the dihedral angle between the phenoxazine ring(C(1)–C(12)) and the benzene ring (C(13)–C(18)) is 82.582°, which indicates that the two rings are not coplanar. In addition, the torsion angle of C14–C13–N1–C6 (110.1°) and C17–C17–C19–C23(−22.9°) can illustrate non-planar property of the molecule. Interestingly the title compound appears to be polymorphic. The structure of a monoclinic, monohydrate form will be the subject of a future publication. All water H atoms are involved in hydrogen bonding; D⃛A distances are in the 2.848(5)–2.946(5) Å range and D-H-A angles in the 153.8–172.2° range. In addition, several other contacts are formed, for instance C16–H16c⃛O3 and C27–H27⃛O2 with d(C⃛O) distance of 3.007 and 2.697 Å, respectively. The distance between the adjacent phenoxazine rings of C(1)–C(12) is 3.422 Å, pointing towards the presence of face–to–face π-π stacking. Other geometric parameters are in expected ranges [16]. To the best of our knowledge, the present structure has not been reported in the literature. The structure of a parent compound has been published earlier [17].


Corresponding author: Meng Hou, Jinan Maternity and Child Care Hospital - Pharmacy, Jianguo Xiaojingsan Road, Jinan, Shandong250000, P. R. China, E-mail:

  1. Author contributions: The authors of Zhuqing Yang and Meng Hou contributed to the work equally and should be regarded as co-first authors.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Rigaku Oxford Diffraction. CrysAlis PRO; Rigaku Corporation: Oxford, UK, 2018.Suche in Google Scholar

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

3. Sheldrick, G. M. SHELXTL – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Suche in Google Scholar

4. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

5. Shirato, K., Imaizumi, K., Abe, A. Phenoxazine derivatives 2-amino-4, 4α-dihydro-4α-phenoxazine-3-one and 2-aminophenoxazine-3-one-induced apoptosis through a caspase-independent mechanism in human neuroblastoma cell line NB-1 cells. Biol. Pharm. Bull. 2007, 30, 331–336; https://doi.org/10.1248/bpb.30.331.Suche in Google Scholar

6. Lin, C. W., Shulok, J. R., Wong, Y. K. Photosensitization, uptake, and retention of phenoxazine Nile blue derivatives in human bladder carcinoma cells. Can. Res. 1991, 51, 1109–1116.Suche in Google Scholar

7. Shimizu, S., Suzuki, M., Tomoda, A. Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria. Tohoku J. Exp. Med. 2004, 203, 47–52; https://doi.org/10.1620/tjem.203.47.Suche in Google Scholar

8. Ishihara, M., Kawase, M., Westman, G. Quantitative structure-cytotoxicity relationship analysis of phenoxazine derivatives by semiempirical molecular-orbital method. Anticancer Res. 2007, 27, 4053–4057.Suche in Google Scholar

9. Karlsson, K. M., Jiang, X., Eriksson, S. K. Phenoxazine dyes. Synfacts 2011, 8.10.1055/s-0030-1260696Suche in Google Scholar

10. Schlereth, D. D., Katz, E., Schmidt, H. L. Surface-modified gold electrodes for electrocatalytic oxidation of NADH based on the immobilization of phenoxazine and phenothiazine derivatives on self-assembled monolayers. Electroanalysis 1995, 7, 46–54; https://doi.org/10.1002/elan.1140070105.Suche in Google Scholar

11. Mori, H., Honda, K., Ishida, R. Antitumor activity of 2-amino-4, 7-dimethyl-3H-phenoxazine-3-one against Meth A tumor transplanted into BALB/c mice. Anti Canc. Drugs 2000, 11, 653–657; https://doi.org/10.1097/00001813-200009000-00010.Suche in Google Scholar

12. Shimamoto, T., Tomoda, A., Ishida, R. Antitumor effects of a novel phenoxazine derivative on human leukemia cell lines in vitro and in vivo. Clin. Canc. Res. 2001, 7, 704–708.Suche in Google Scholar

13. Tian, H., Bora, I., Jiang, X. Modifying organic phenoxazine dyes for efficient dye-sensitized solar cells. J. Mater. Chem. 2011, 21, 12462–12472; https://doi.org/10.1039/c1jm12071a.Suche in Google Scholar

14. Tan, H., Pan, C., Wang, G. A comparative study on properties of two phenoxazine-based dyes for dye-sensitized solar cells. Dyes Pigments 2014, 101, 67–73; https://doi.org/10.1016/j.dyepig.2013.09.039.Suche in Google Scholar

15. He, J., Pei, H., Li, H. Comparative analysis of phenothiazine and phenoxazine sensitizers for dye-sensitized solar cells. Synth. Met. 2019, 247, 228–232; https://doi.org/10.1016/j.synthmet.2018.12.006.Suche in Google Scholar

16. Sridhar, M. A., Ramegowda, M., Lokanath, N. K. Structural studies of some phenoxazine derivatives. Mol. Cryst. Liq. Cryst. Sci. Technol., Sect. A 2009, 326, 189–214.10.1080/10587259908025415Suche in Google Scholar

17. Liu, N., Wang, B., Chen, W., Liu, C., Wang, X., Hu, Y. A general route for synthesis of N-aryl phenoxazines via copper(I)-catalyzed N-, N-, and O-arylations of 2-aminophenols. RSC Adv. 2014, 4, 51133–51139; https://doi.org/10.1039/c4ra09593f.Suche in Google Scholar

Received: 2021-01-04
Accepted: 2021-02-01
Published Online: 2021-02-17
Published in Print: 2021-05-26

© 2021 Zhuqing Yang and Meng Hou, published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of bis(μ2-5-chloro-2-oxido-N-(1-oxidoethylidene)benzohydrazonato-κ5N,O,O′:N′,O′′)hexkis(pyridine-κ1N)trinickel(II) - pyridine (1/1), C63H57Cl2N13Ni3O6
  4. Crystal structure of [(μ2-succinato κ3O,O′:O′′)-bis-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane)]dinickel(II)] diperchlorate, dihydrate C36H82Cl2N8Ni2O15
  5. Crystal structure of catena-poly[aquabis(3-nitrobenzoato-κ2O:O′)-(μ2-pyrazine-N: N′)cadmium(II)], C18H14N4O9Cd
  6. Crystal structure of 4-(2,2-difluoroethyl)-2,4,6-trimethylisoquinoline-1,3(2H,4H)-dione, C14H15F2NO2
  7. The crystal structure of thioxanthen-9-one-10,10-dioxide, C13H8O3S – a second polymorph
  8. Crystal structure of (E)-2-((2-methoxy-3-pyridyl)methylene)-7-fluoro-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
  9. The crystal structure of diaquahydrogen 2,5-dimethylbenzenesulphonate, C8H14O5S
  10. The crystal structure of N-(4-(cyclohexylimino)pent-2-en-2-yl)cyclohexanamine, C17H30N2
  11. The twinned crystal structure of 1,3-phenylenedimethanaminium dibromide, C8H14Br2N2
  12. Crystal structure of 2,4,7,9-tetranitro-10H-benzofuro[3,2-b]indole – dimethyl sulfoxide (1/1), C16H11N5O10S
  13. Crystal structure of 2,6-bis(2-(pyridin-3-yl)ethyl)pyrrolo[3,4-f]isoindole-1,3,5,7(2H,6H)-tetraone, C24H18N4O4
  14. The crystal structure of 3,4-dichlorobenzoic acid chloride, C7H3Cl3O
  15. Crystal structure of 1,1′-(1,4-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-k2S:S)zinc(II), C26H18N6ZnS4
  16. Crystal structure of tetrakis(μ-naphthalene-1-carboxylato-κ2O,O′)bis(methanol)copper(II), C46H36Cu2O10
  17. Crystal structure of 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one, C14H13NO
  18. Crystal structure of bis(amino(carbamothioylamino)methaniminium) 3-nitrophthalate monohydrate, C12H19N9O7S2
  19. Crystal structure of 3,3′-(1,2-phenylene-bis(methylene))bis(1-ethyl-1H-imidazol-3-ium) bis(hexafluorophosphate), C18H24F12N4P2
  20. The crystal structure of 5-hydroxy-6,8-dimethoxy-2-methyl-4H-benzo[g]chromen-4-one– rubrofusarin B, C16H14O5
  21. The crystal structure of bis(ethanol-kO)- bis(6-aminopicolinato-k2N,O)manganese(II), C16H22O6N4Mn
  22. The crystal structure of 3,3′-((carbonylbis(azanediyl))bis(ethane-2,1-diyl)) bis(1-methyl-1H-benzo[d]imidazol-3-ium) tetrafluoroborate monohydrate, C21H28N6O3B2F8
  23. Crystal structure of dimethanol-dichlorido-bis( μ2-2-(((1,5-dimethyl-3-oxo-2- phenyl-2,3-dihydro-1H-pyrazol-4-yl)imino)methyl)phenolato- κ4O:O,O′,N)dinickel (II), C20H24ClNiN3O4
  24. The crystal structure of methyl 5-(trifluoromethyl)-1H-pyrrole-2-carboxylate, C7H6F3NO2
  25. Crystal structure of (OC‐6‐13)‐aqua‐tris (3‐bromopyridine‐κ1N)‐bis(trifluoroacetato‐κ1O)cadmium(II) C19H14Br3CdF6N3O5
  26. Crystal structure of methyl (E)-3-(4-(2-ethoxy-2-oxoethoxy)phenyl) acrylate, C14H16O5
  27. Crystal structure of methyl 4-acetoxy-3,5-dimethoxybenzoate, C12H14O6
  28. The crystal structure of 2-(1H-benzimidazol-2-yl)-3-bromo-5-chlorophenol, C13H8BrClN2O
  29. The crystal structure of bis(μ2-5-chloro-N-(2-methyl-1-oxidopropylidene)-2-oxidobenzohydrazonate-κ5N,O,O′:N′,O′′)pentakis(pyridine-κ1N)tricopper(II), C47H45Cl2N9Cu3O6
  30. Synthesis and crystal structure of catena-poly[aqua-bis(nitrato-κ2O:O′)- (μ2-((1 H-imidazol-1-yl)methyl)benzene-κ2 N,N′)-H2O-κ2O]cadmium(II), C14H16N6O7Cd
  31. The crystal structure of pentakis(carbonyl)-{μ-[2,3-bis(sulfanyl)propan-1-olato]}-(triphenylphosphane)diiron (FeFe)C26H21Fe2O6PS2
  32. Crystal structure of ethyl-2-(3-benzoylthioureido)propanoate, C13H16N2O3S
  33. Crystal structure of 2-methoxy-4b,5,14,15-tetrahydro-6H-isoquinolino[2′,1′:1,6] pyrazino[2,3-b]quinoxaline, C19H18N4O
  34. Crystal structure of 2,2′-[ethane-1,2-diylbis(azanylylidenemethylylidene)]bis(6-chlorophenol), C16H14Cl2N2O2
  35. The crystal structure of (Z)-3-((2-(2-(2-aminophenoxy)ethoxy)phenyl)amino)-1-phenylbut-2-en-1-one, C24H24N2O3
  36. The crystal structure of 10-(3,5-di(pyridin-4-yl)phenyl)-10H-phenoxazine dihydrate, C28H23N3O3
  37. Crystal structure of poly[dipoly[aqua-di(µ2-pyrazin-2-olato-κ2N:N′) zinc(II)], C8H8N4O3Zn
  38. Crystal structure of poly[tetra(μ2-cyanido-κ2N:O)-bis(N,N-dimethylformamide-κO)-manganese(II)-platinum(II)], C10H14MnN6O2Pt
  39. The crystal structure of aqua-chlorido-6,6′-((ethane-1,2-diylbis(azaneylylidene))bis(methaneylylidene))bis(2,4-dichlorophenolato-κ4N,N′,O,O′)manganese(III), C16H12Cl5MnN2O3
  40. Crystal structure of [di(µ2-cyanido)-dicyanido-bis(dimethyl sulfoxide-κO)- bis(2,2′-(ethane-1,2-diylbis(azanylylidenemethanylylidene))diphenolato-κ4,N,N′,O,O′)- dimanganese(III)-platinum(II)], C40H40Mn2N8O6PtS2
  41. The crystal structure of (azido)-κ1N-6,6′-((cyclohexane-1,2-diylbis(azanylylidene)) bis(methanylylidene))bis(3-bromophenolato-κ4N,N,O,O)-(methanol)-manganese(III)–methanol(1/1), C22H26Br2MnN5O4
  42. Crystal structure of 7-chloro-N-(4-iodobenzyl)-1,2,3,4-tetrahydroacridin-9-amine, C20H18ClIN2
  43. Crystal structure of catena-poly[(1,4,8,11-tetraazacyclotetradecane-κ4N,N,N,N′′′)-bis(μ2-thiocyanato-κ2N:S)-bis(thiocyanato-κS)-nickel(II)palladium(II)], C14H24N8NiPdS4
  44. Crystal structure of 3-chloro-4-(4-ethylpiperazin-1-yl)aniline monohydrate, C12H20ClN3O
  45. Crystal structure of the 2D coordination polymer poly[diaqua-bis(μ2-3- methoxyisonicotinato-κ2N:O)cobalt(II)] — dimethylformamide (1/1), C20H30CoN4O10
  46. Crystal structure of 4-[(5-chloro-2-hydroxybenzylidene)amino]-3-propyl-1H-1,2,4-triazole-5(4H)-thione, C12H13ClN4OS
  47. Crystal structure of N-(5-(2-(benzyl(1-(4-methoxyphenyl)propan-2-yl)amino)-1-hydroxyethyl)-2-(benzyloxy)phenyl)formamide, C33H36N2O4
  48. Crystal structure of 3-(methoxycarbonyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid, C9H12O5
  49. The crystal structure of 1-((dimethylamino)(3-nitrophenyl)methyl)naphthalen-2-ol, C19H18N2O3
  50. Crystal structure of catena-poly[di(μ2-cyanido-κ2C:N)-dicyanido-tetrakis(dimethyl sulfoxide-κO)-manganese(II)-platinum(II)], C12H24MnN4O4PtS4
  51. Crystal structure of 4-amino-N-(2-pyrimidinyl)benzenesulfonamide–1,4-dioxane (1/1), C14H18N4O4S
  52. Crystal structure of bis{1-[(benzotriazol-1-yl)methyl]-1H-1,3-(2-methyl-imidazol)}di-chloridomercury(II), [Hg(C11H11N5)2Cl2], C22H22N10Cl2Hg
  53. Crystal structure of 2, 3-bis((4-methylbenzoyl)oxy) succinic acid–N, N-dimethylformamide (1/1), C23H25NO9
  54. Crystal structure of catena-poly[bis(4-(4-carboxyphenoxy)benzoato-κ1O)-μ2-(1,4-bis(1-imidazolyl)benzene-κ2N:N′)cobalt(II)], C40H28N4O10Co
  55. Crystal structure of 1H-imidazol-3-ium poly[aqua-(μ4-glutarato-κ6O,O′:O′:O′′,O′′′:O′′′)-(nitrato-κ2O,O′)strontium(II)], C8H13N3O8Sr
  56. Crystal structure of (R)-6-(benzo[b]thiophen-5-yl)-2-methyl-2,6-dihydrobenzo [5,6] silino[4,3,2-cd]indole, C23H17NSSi
  57. Crystal structure of catena-poly[bis(μ2-thiocyanato-κ2N:S)-(2-(5-methyl-1H-pyrazol-3-yl)pyridine-κ2N,N′)cadmium(II)]–dioxane (1/1), C15H17CdN5O2S2
  58. Crystal structure of poly[aqua-(μ2-1,4-bis(2′-carboxylatophenoxy)benzene-κ2O:O′)-(μ2-4,4′-bipyridione-κ2N:N′)cadmium(II)] monhydrate, C30H22CdN2O7⋅H2O
  59. Crystal structure of catena-poly[tetraaqua-(μ2-4,4′-bipyridine-k2N:N′)-bis(μ2-4′-methyl-[1,1′-biphenyl]-3,5-dicarboxylato-k4O,O′:O″,O′″)dicadmium(II)] dihydrate, C20H20NO7Cd
  60. Crystal structure of 1‐tert‐butyl‐3‐(2,6‐diisopropyl‐4‐phenoxyphenyl)‐2-methylisothiourea, C24H34N2OS
  61. Crystal structure of catena-poly[triaqua-(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2N:N′)-(4,4′-(1H-1,2,4-triazole-3,5-diyl)dibenzoato-κ1O)cobalt(II)] — N,N′-dimethylformamide (1/1), C28H34N8O8Co
  62. Crystal structure of tetraaqua-bis(1,4-di(1H-imidazol-1-yl)benzene-κ1N)manganese(II) 2,3-dihydroxyterephthalate, C32H32MnN8O10
Heruntergeladen am 9.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0001/html?lang=de
Button zum nach oben scrollen